Oklo Secures NRC Isotope License and DOE Safety Design Approval for Aurora Reactor
Oklo's Atomic Alchemy subsidiary secured the U.S. NRC materials license allowing commercial isotope sales from its Idaho Radiochemistry Lab for medicine, research, advanced manufacturing and national security. The U.S. DOE also greenlit the Nuclear Safety Design Agreement for Oklo's first Aurora reactor at Idaho National Laboratory.
1. NRC Materials License Granted
Oklo's Atomic Alchemy subsidiary received the U.S. Nuclear Regulatory Commission materials license authorizing it to handle, process and distribute radioactive isotopes. The permit covers initial commercial sales from the company's Idaho Radiochemistry Laboratory, targeting medical, research, advanced manufacturing and national security sectors.
2. DOE Safety Design Agreement Approved
Under a DOE Other Transaction Agreement within the Reactor Pilot Program, Oklo secured approval for its Nuclear Safety Design Agreement for the Aurora powerhouse at Idaho National Laboratory. This milestone clears key regulatory hurdles for the design, construction and operation of the company's first fast-fission reactor.
3. Stock Reaction and Future Catalysts
Shares of Oklo surged as much as 5%, testing the $63 level after the licensing news, reflecting investor optimism. Market participants are now focused on upcoming earnings and construction timelines for the Aurora reactor as potential catalysts for further gains.